MET MetLife
Quality insurer at 2.3x AOCI-depressed book; the price already assumes mid-teens ROE, leaving little margin of safety.
The story
MetLife is a scaled global life, group benefits and retirement franchise whose earnings increasingly come from fee-like group benefits, Asia, and pension risk transfer, backed by a high-quality but rate-sensitive fixed-income portfolio. Reported book of $28.4B is held down by large AOCI unrealized bond losses, so GAAP ROE of 12.8% understates the economics. Adjusted operating ROE (excluding AOCI) runs in the low-to-mid teens, and GAAP net income is hit by derivative and hedge marks. The company is mid-cycle, with heavy buybacks, solid capital (RBC well above 360%), and the main exposures in commercial real estate loans, private credit, and spread compression if rates fall.
Normalized ROE of 14.5% on reported book sits between trailing GAAP (12.8%) and adjusted operating earnings on the AOCI-depressed book (high teens), discounting non-recurring hedge noise and credit normalization. Book growth stays modest because roughly 60-70% of earnings goes back to shareholders through dividends and buybacks, and terminal growth of 3.5% is below the 5.12% risk-free rate. Beta of 1.0 sits slightly above the 0.9 anchor to reflect leverage and spread-credit exposure.
Value drivers
| Return on equity (normalized) | 14.5% |
| Book-value growth (Y1) | 4.0% |
| Terminal book growth | 3.5% |
| Beta | 1.00 |
| Failure probability | 1.0% |
| Cost of equity | 9.6% |
Valuation bridge
| PV of excess returns | 7.37B |
| PV of terminal excess | 5.36B |
| Equity value | 40.72B |
| ÷ shares → per share | $64.07 |
Projected excess returns on equity
| Yr | Book equity | ROE | Excess return | PV |
|---|---|---|---|---|
| 1 | 28.40B | 14.5% | 1.39B | 1.27B |
| 2 | 29.53B | 14.2% | 1.35B | 1.12B |
| 3 | 30.70B | 13.9% | 1.30B | 988.77M |
| 4 | 31.89B | 13.5% | 1.25B | 866.34M |
| 5 | 33.12B | 13.2% | 1.19B | 753.60M |
| 6 | 34.37B | 12.9% | 1.13B | 650.00M |
| 7 | 35.65B | 12.6% | 1.06B | 555.01M |
| 8 | 36.95B | 12.3% | 975.79M | 468.09M |
| 9 | 38.29B | 11.9% | 888.38M | 388.78M |
| 10 | 39.65B | 11.6% | 792.96M | 316.57M |
Key risks
- Commercial real estate and private credit losses in the general account eroding book and ROE
- Spread compression and lower reinvestment yields if rates fall, offsetting the AOCI recovery
- Reserve or assumption charges (mortality, morbidity, long-term care legacy) and FX drag on Japan/Latin America
Catalysts
- AOCI recovery and continued $3B+ annual buybacks lifting per-share book and ROE toward the 15-17% target
- Growth in pension risk transfer and asset management (MIM) shifting the mix toward capital-light fee earnings